Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Study from the Adult Acute Lymphoblastic Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy

Kimimori Kamijo, Yoshimitsu Shimomura, Takayoshi Tachibana, Yuho Najima, Jun Aoki, Yu Akahoshi, Masatsugu Tanaka, Noriko Doki, Naoyuki Uchida, Hiroyuki Ohigashi, Hikaru Kobayashi, Shuichi Ota, Miho Nara, Shinichiro Fujiwara, Yasuo Mori, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Yasuyuki Arai

Blood (2023) 142 (Supplement 1): 4958.

https://doi.org/10.1182/blood-2023-180602

Published: 2023

Journal Articles

Outcomes of Hematopoietic Cell Transplantation for Patients with Refractory Cytopenia with Multilineage Dysplasia: A Comparison Children with Adolescents and Young Adults

Blood (2023) 142 (Supplement 1): 2202.

https://doi.org/10.1182/blood-2023-189000

Published: 2023

Journal Articles

Prognostic Impact of Conditioning Intensity on Outcomes after Allogeneic Transplantation for MDS with Low Blasts

Hidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, Ken Ishiyama, Jun Aoki, Noriko Doki, Tetsuya Nishida, Takahiro Fukuda, Naoyuki Uchida, Yasunori Ueda, Yasufumi Uehara, Yuta Katayama, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta

Blood (2023) 142 (Supplement 1): 4985.

https://doi.org/10.1182/blood-2023-173567

Published: 2023

Journal Articles

Very Low-Dose Dasatinib Is a Safe and Effective Therapy for Elderly Patients with Newly-Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results from the Davlec Study, a Single-Arm, Multicenter, Phase 2 Trial

Blood (2021) 138 (Supplement 1): 3601.

https://doi.org/10.1182/blood-2021-149483

Published: 2021

Journal Articles

Value of Computed Tomography-Defined Sarcopenia: A Prognostic Predictor of Non-Relapse Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Taiki Ando, MD, Shin Fujisawa, MD PhD, Takayuki Sakuma, MD, Haruka Teshigawara, MD, Ayako Matsumura, MD, Taisei Suzuki, MD, Hiroshi Teranaka, MD, Akiko Negoro, MD, Eriko Ogusa, MD, Jun Aoki, MD PhD, Kazuho Miyashita, MD PhD, Yoshimi Ishii, MD PhD, Hiroyuki Takahashi, MD PhD, Yuki Nakajima, MD PhD, Takuya Miyazaki, MD PhD, Maki Hagihara, MD PhD, Kenji Matsumoto, MD PhD, Etsuko Yamazaki, MD PhD, Hideaki Nakajima, MD PhD

Blood (2017) 130 (Supplement 1): 4562.

https://doi.org/10.1182/blood.V130.Suppl_1.4562.4562

Published: 2017

Journal Articles

Clinical Impact of Sarcopenia and Skeletal Muscle Mass Change during Chemotherapy on Outcomes of Diffuse Large B-Cell Lymphoma

Hiroshi Teranaka, MD, Shin Fujisawa, MD PhD, Takayuki Sakuma, MD, Haruka Teshigawara, MD, Ayako Matsumura, MD, Taiki Ando, MD, Taisei Suzuki, MD, Akiko Negoro, MD, Eriko Ogusa, MD, Jun Aoki, MD PhD, Kazuho Miyashita, MD PhD, Yoshimi Ishii, MD PhD, Hiroyuki Takahashi, MD PhD, Yuki Nakajima, MD PhD, Takuya Miyazaki, MD PhD, Maki Hagihara, MD PhD, Kenji Matsumoto, MD PhD, Etsuko Yamazaki, MD PhD, Hideaki Nakajima, MD PhD

Blood (2017) 130 (Supplement 1): 5221.

https://doi.org/10.1182/blood.V130.Suppl_1.5221.5221

Published: 2017

Journal Articles

Prognostic Impact of Delayed Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancy

Heiwa Kanamori, MD, Jun Aoki, MD, Eriko Ogusa, MD, Akiko Negoro, MD, Satoshi Koyama, MD, Takayoshi Tachibana, MD, Masatsugu Tanaka, MD, Hideaki Nakajima, MD PhD

Blood (2016) 128 (22): 3407.

https://doi.org/10.1182/blood.V128.22.3407.3407

Published: 2016

Journal Articles

Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Patients 50 Years or Older

Koji Kawamura, MD, Shinichi Kako, MD, Shuichi Mizuta, MD PhD, Ken Ishiyama, MD PhD, Jun Aoki, MD, Shingo Yano, MD PhD, Takahiro Fukuda, MD, Naoyuki Uchida, MD PhD, Yukiyasu Ozawa, MD PhD, Tetsuya Eto, MD PhD, Koji Iwato, MD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2016) 128 (22): 3414.

https://doi.org/10.1182/blood.V128.22.3414.3414

Published: 2016

Journal Articles

Prognostic Impact of Pre-Transplant Serum C-Reactive Protein in Patients Receiving a Single-Unit Unrelated Cord Blood Transplantation

Akiko Negoro, MD, Heiwa Kanamori, MD, Jun Aoki, MD, Satoshi Koyama, MD, Takayoshi Tachibana, MD, Masatsugu Tanaka, MD, Hideaki Nakajima, MD

Blood (2016) 128 (22): 5853.

https://doi.org/10.1182/blood.V128.22.5853.5853

Published: 2016

Journal Articles

Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia Harboring t(7;11)(p15;p15)

Kaito Harada, MD, Noriko Doki, Jun Aoki, MD, Jinichi Mori, MD, Shinichiro Machida, MD, Yuho Najima, Naoyuki Uchida, MD PhD, Takahiro Fukuda, MD, Heiwa Kanamori, MD, Hiroyasu Ogawa, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Shingo Yano, MD PhD

Blood (2016) 128 (22): 4654.

https://doi.org/10.1182/blood.V128.22.4654.4654

Published: 2016

Journal Articles

Impact of Unbalanced Translocation Der(1;7)(q10;p10) and -7/Del(7q) on the Prognostic Value after Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes: A Nationwide Retrospective Study

Hidehiro Itonaga, MD PhD, Kazunari Aoki, MD, Jun Aoki, MD, Ken Ishiyama, MD PhD, Takayuki Ishikawa, MD, PhD, Kazuteru Ohashi, MD FACP, Takahiro Fukuda, MD, Yukiyasu Ozawa, MD, Naoki Kobayashi, MD, Naoyuki Uchida, Tetsuya Eto, MD PhD, Minoko Takanashi, MD PhD, Tatsuo Ichinohe, MDPhD, Yoshiko Atsuta, MDPhD, Yasushi Miyazaki, MD PhD

Blood (2015) 126 (23): 3206.

https://doi.org/10.1182/blood.V126.23.3206.3206

Published: 2015

Journal Articles

Comparable Leukemia-Free Survival after Autologous Hematopoietic Cell Transplantation Versus HLA-Identical Sibling Hematopoietic Cell Transplantation for Adult Acute Myeloid Leukemia in First Complete Remission: A Registry Study By the Adult AML Working Group of the Japan Society for Hematopoietic Cell Transplantation

Motonori Mizutani, MD, Masahiko Hara, Hiroyuki Fujita, Jun Aoki, Heiwa Kanamori, Shinichiro Machida, Satoshi Yamasaki, MD PhD, Kazuteru Ohashi, MD PhD, Kensuke Usuki, MDPhD, Takahiro Fukuda, MD, Takaaki Chou, Junji Tanaka, MD PhD, Yoshiko Atsuta, MDPhD, Akiyoshi Takami, MD PhD

Blood (2014) 124 (21): 2514.

https://doi.org/10.1182/blood.V124.21.2514.2514

Published: 2014

Journal Articles

Impact of Low-Dose TBI on Outcome of Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation from HLA Identical Sibling for Acute Myeloid Leukemia

Jun Aoki, MD, Sachiko Seo, MD, Masatsugu Tanaka, MD, Heiwa Kanamori, Takahiro Fukuda, MD, Naoki Kobayashi, MD PhD, Makoto Onizuka, MD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MDPhD, Akiyoshi Takami

Blood (2014) 124 (21): 3893.

https://doi.org/10.1182/blood.V124.21.3893.3893

Published: 2014

Journal Articles

Moving Average Of Immature Platelet Fraction Predict Late Platelet Engraftment After Reduced-Intensity Cord Blood Transplantation: A Single-Institutional Study

Kanichi Iwama, MD, Jun Aoki, MD, Noriyuki Tadera, MD, Daisuke Sinoda, MD, Kouichi Kaziwara, MD, Hideki Kodo, MD, Yasuzi Kouzai, MD

Blood (2013) 122 (21): 4583.

https://doi.org/10.1182/blood.V122.21.4583.4583

Published: 2013

Journal Articles

Influence Of Acute and Chronic Graft-Versus-Host Disease On Outcome After Allogeneic Hematopoietic Stem Cell Transplantation For Chronic Myelomonocytic Leukemia

Hidehiro Itonaga, MD, PhD, Masako Iwanaga, MD, PhD, MPH, Kazunari Aoki, MD, Jun Aoki, MD, Ken Ishiyama, MD, PhD, Takeshi Kobayashi, MD, Toru Sakura, MD, PhD, Takahiro Fukuda, MD, Toshiaki Yujiri, MD, Makoto Hirokawa, MD, PhD, Yasuo Morishima, Tokiko Nagamura-Inoue, MD, PhD., Yoshiko Atsuta, MD, Takayuki Ishikawa, M.D., Ph.D., Yasushi Miyazaki, MD, PhD

Blood (2013) 122 (21): 2102.

https://doi.org/10.1182/blood.V122.21.2102.2102

Published: 2013

Journal Articles

The Clinical Significance Of Diastolic Dysfunction On The Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Naoki Shingai, MD, Kazuhiko Kakihana, MD, PhD, Shuntaro Ikegawa, MD, Yukie Takahashi, MD, Jun Aoki, MD, Kosuke Yoshioka, MD, Kensuke Narukawa, M.D., Ph.D., Shinya Ishida, MD, Aiko Igarashi, MD, Takeshi Kobayashi, MD, Noriko Doki, MD, PhD, Ohashi Kazuteru, MD, PhD, Hisashi Sakamaki, MD, PhD

Blood (2013) 122 (21): 4550.

https://doi.org/10.1182/blood.V122.21.4550.4550

Published: 2013

Journal Articles

Gemtuzumab Ozogamicin After Allogeneic Stem Cell Transplantation for Acute Leukemia

Takeshi Kobayashi, MD, Naoki Shingai, MD, Shuntaro Ikegawa, MD, Yukie Takahashi, MD, Jun Aoki, MD, Kosuke Yoshioka, MD, Jinichi Mori, MD, Megumi Yasunaga, MD, Yoshio Umezawa, MD, Gaku Oshikawa, MD, Noriko Doki, MD, Kazuhiko Kakihana, MD, PhD, Kazuteru Ohashi, M.D., Hisashi Sakamaki, MD

Blood (2012) 120 (21): 1970.

https://doi.org/10.1182/blood.V120.21.1970.1970

Published: 2012

Journal Articles

Plasmablasts evolving from low-grade lymphoma

Jun Aoki, Kazuhiko Kakihana

Blood (2012) 119 (10): 2185.

https://doi.org/10.1182/blood-2011-06-356360

Published: 2012

NARROW

Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Study from the Adult Acute Lymphoblastic Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy

Outcomes of Hematopoietic Cell Transplantation for Patients with Refractory Cytopenia with Multilineage Dysplasia: A Comparison Children with Adolescents and Young Adults

Prognostic Impact of Conditioning Intensity on Outcomes after Allogeneic Transplantation for MDS with Low Blasts

Very Low-Dose Dasatinib Is a Safe and Effective Therapy for Elderly Patients with Newly-Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results from the Davlec Study, a Single-Arm, Multicenter, Phase 2 Trial

Value of Computed Tomography-Defined Sarcopenia: A Prognostic Predictor of Non-Relapse Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Clinical Impact of Sarcopenia and Skeletal Muscle Mass Change during Chemotherapy on Outcomes of Diffuse Large B-Cell Lymphoma

Prognostic Impact of Delayed Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancy

Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Patients 50 Years or Older

Prognostic Impact of Pre-Transplant Serum C-Reactive Protein in Patients Receiving a Single-Unit Unrelated Cord Blood Transplantation

Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia Harboring t(7;11)(p15;p15)

Impact of Unbalanced Translocation Der(1;7)(q10;p10) and -7/Del(7q) on the Prognostic Value after Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes: A Nationwide Retrospective Study

Impact of Low-Dose TBI on Outcome of Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation from HLA Identical Sibling for Acute Myeloid Leukemia

Moving Average Of Immature Platelet Fraction Predict Late Platelet Engraftment After Reduced-Intensity Cord Blood Transplantation: A Single-Institutional Study

Influence Of Acute and Chronic Graft-Versus-Host Disease On Outcome After Allogeneic Hematopoietic Stem Cell Transplantation For Chronic Myelomonocytic Leukemia

The Clinical Significance Of Diastolic Dysfunction On The Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Gemtuzumab Ozogamicin After Allogeneic Stem Cell Transplantation for Acute Leukemia

Plasmablasts evolving from low-grade lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only